The Uromigos
Ein Podcast von The Uromigos
401 Folgen
-
Episode 343: ESMO 2024 - TiNivo-2 Trial
Vom: 14.9.2024 -
Episode 342: ESMO 2024 Preview with Silke Gillessen
Vom: 3.9.2024 -
Episode 341: Hormone Resistance in Prostate Cancer
Vom: 27.8.2024 -
Episode 340: Cancer Immunity Cycle Update
Vom: 19.8.2024 -
Episode 339: Tres Uramigas analizan lineamientos de ESMO para GU
Vom: 9.8.2024 -
Episode 338: RCC: Debulking Nephrectomy, Adjuvant Therapy Future and More
Vom: 6.8.2024 -
Episode 337: Updated NCCN Guidelines in RCC
Vom: 30.7.2024 -
Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer
Vom: 24.7.2024 -
Episode 335: Novel immune therapies for renal cancer
Vom: 19.7.2024 -
Episodio 334 en español: Tres Uramigas ASCO 2024
Vom: 11.7.2024 -
Episode 333: The Uromigos Cup - The Netherlands
Vom: 5.7.2024 -
Episode 332: The Uromigos Cup - Germany's Entry
Vom: 26.6.2024 -
Episode 331: AUA 2024 NMIBC Highlights
Vom: 21.6.2024 -
Episode 330: ASCO 2024 Highlights
Vom: 10.6.2024 -
Episode 329: Japan in the Uromigos Cup qualifying round
Vom: 7.6.2024 -
Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies
Vom: 5.6.2024 -
Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates
Vom: 4.6.2024 -
Episode 326 ASCO24: KIM-1 in Renal Cancer
Vom: 3.6.2024 -
Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer
Vom: 3.6.2024 -
Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC
Vom: 2.6.2024
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
